Soleus Capital Management, L.P. - JASPER THERAPEUTICS INC ownership

JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 42 filers reported holding JASPER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of JASPER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,810,686
-45.5%
8,300,980
+6.8%
0.54%
-54.7%
Q2 2023$10,653,093
-21.1%
7,775,980
+4.3%
1.18%
-15.2%
Q1 2023$13,493,5147,454,9801.40%
Other shareholders
JASPER THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 5,852,982$20,778,00019.52%
Velan Capital Investment Management LP 3,219,036$10,180,0009.45%
Abingworth LLP 5,628,558$19,531,0005.54%
SECTORAL ASSET MANAGEMENT INC 675,000$2,396,0000.42%
KINGDON CAPITAL MANAGEMENT, L.L.C. 540,000$1,917,0000.20%
Vahanian & Associates Financial Planning Inc. 10,000$36,0000.08%
Forefront Analytics, LLC 32,550$118,0000.04%
Citadel Advisors 2,994,580$10,631,0000.00%
FEDERATED HERMES, INC. 251,697$894,0000.00%
Ionic Capital Management LLC 100$00.00%
View complete list of JASPER THERAPEUTICS INC shareholders